SANUWAVE Health, Inc. (SNWV)
USD 30.41
(2.03%)
USD 30.41
(2.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -9.15 Million USD | 104.27% |
| 2022 | -8 Million USD | 30.61% |
| 2021 | -18.9 Million USD | -0.46% |
| 2020 | -27.38 Million USD | -88.04% |
| 2019 | -8.53 Million USD | -22.04% |
| 2018 | -7.11 Million USD | -88.34% |
| 2017 | -4.37 Million USD | -423.12% |
| 2016 | -2.99 Million USD | 83.39% |
| 2015 | -4.22 Million USD | 22.6% |
| 2014 | -5.19 Million USD | 0.13% |
| 2013 | -9.08 Million USD | 1.36% |
| 2012 | -5.74 Million USD | 23.89% |
| 2011 | -8.54 Million USD | 28.34% |
| 2010 | -10.5 Million USD | -31.62% |
| 2009 | -7.77 Million USD | -30335.61% |
| 2008 | -10.83 Million USD | 23.03% |
| 2007 | -34.05 Thousand USD | -156.28% |
| 2006 | -13.28 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -686 Thousand USD | -103.47% |
| 2024 Q2 | 2.25 Million USD | 400.53% |
| 2023 Q2 | 1.12 Million USD | 164.55% |
| 2023 FY | - USD | 104.27% |
| 2023 Q3 | -157 Thousand USD | -113.93% |
| 2023 Q4 | 1.28 Million USD | 919.75% |
| 2023 Q1 | -1.74 Million USD | 36.39% |
| 2022 FY | - USD | 30.61% |
| 2022 Q2 | -1.94 Million USD | 62.04% |
| 2022 Q1 | -5.13 Million USD | -144.41% |
| 2022 Q3 | -1.6 Million USD | 17.65% |
| 2022 Q4 | -2.74 Million USD | -71.03% |
| 2021 Q1 | -4.12 Million USD | 17.69% |
| 2021 FY | - USD | -0.46% |
| 2021 Q2 | -6.25 Million USD | -51.55% |
| 2021 Q3 | -4 Million USD | 35.95% |
| 2021 Q4 | -2.1 Million USD | 47.51% |
| 2020 Q3 | -5.44 Million USD | -69.63% |
| 2020 FY | - USD | -88.04% |
| 2020 Q1 | -2.74 Million USD | -9.81% |
| 2020 Q2 | -3.2 Million USD | -16.96% |
| 2020 Q4 | -5.01 Million USD | 7.92% |
| 2019 Q4 | -2.49 Million USD | -5.69% |
| 2019 FY | - USD | -22.04% |
| 2019 Q1 | -1.85 Million USD | -47.63% |
| 2019 Q2 | -2.01 Million USD | -8.53% |
| 2019 Q3 | -2.36 Million USD | -17.57% |
| 2018 Q1 | -1.11 Million USD | -21.2% |
| 2018 FY | - USD | -88.34% |
| 2018 Q4 | -1.25 Million USD | 52.92% |
| 2018 Q3 | -2.66 Million USD | -26.13% |
| 2018 Q2 | -2.11 Million USD | -89.26% |
| 2017 Q2 | -1.34 Million USD | -43.44% |
| 2017 FY | - USD | -423.12% |
| 2017 Q1 | -934.36 Thousand USD | -248.51% |
| 2017 Q4 | -920.98 Thousand USD | -53.56% |
| 2017 Q3 | -599.74 Thousand USD | 55.25% |
| 2016 Q4 | 629.17 Thousand USD | 193.29% |
| 2016 Q1 | 186.73 Thousand USD | 116.49% |
| 2016 Q3 | -674.4 Thousand USD | 28.8% |
| 2016 FY | - USD | 83.39% |
| 2016 Q2 | -947.25 Thousand USD | -607.28% |
| 2015 Q4 | -1.13 Million USD | 31.07% |
| 2015 Q1 | -1.04 Million USD | -24.66% |
| 2015 FY | - USD | 22.6% |
| 2015 Q3 | -1.64 Million USD | -231.14% |
| 2015 Q2 | -496.02 Thousand USD | 52.73% |
| 2014 Q1 | -1.93 Million USD | -69.11% |
| 2014 Q4 | -841.71 Thousand USD | 36.67% |
| 2014 Q3 | -1.32 Million USD | 13.27% |
| 2014 Q2 | -1.53 Million USD | 20.87% |
| 2014 FY | - USD | 0.13% |
| 2013 Q2 | -3.96 Million USD | -248.3% |
| 2013 Q3 | -1.8 Million USD | 54.44% |
| 2013 Q4 | -1.14 Million USD | 36.68% |
| 2013 FY | - USD | 1.36% |
| 2013 Q1 | 2.67 Million USD | 276.86% |
| 2012 Q1 | -1.67 Million USD | -23.16% |
| 2012 Q2 | -1.25 Million USD | 24.99% |
| 2012 Q3 | -1.28 Million USD | -2.2% |
| 2012 Q4 | -1.51 Million USD | -17.88% |
| 2012 FY | - USD | 23.89% |
| 2011 Q3 | -2 Million USD | -106.93% |
| 2011 Q4 | -1.35 Million USD | 32.15% |
| 2011 Q2 | -968.5 Thousand USD | 50.91% |
| 2011 FY | - USD | 28.34% |
| 2011 Q1 | -1.97 Million USD | 41.44% |
| 2010 Q3 | -2.22 Million USD | 3.97% |
| 2010 Q4 | -3.36 Million USD | -51.38% |
| 2010 FY | - USD | -31.62% |
| 2010 Q1 | -2.58 Million USD | -14.13% |
| 2010 Q2 | -2.31 Million USD | 10.48% |
| 2009 Q2 | -4886.00 USD | 6.67% |
| 2009 Q1 | -5235.00 USD | -121.17% |
| 2009 Q4 | -2.26 Million USD | 8.9% |
| 2009 FY | - USD | -30335.61% |
| 2009 Q3 | -2.49 Million USD | -50864.8% |
| 2008 FY | - USD | 23.03% |
| 2008 Q4 | -2367.00 USD | 67.43% |
| 2008 Q3 | -7267.00 USD | 50.84% |
| 2008 Q2 | -14.78 Thousand USD | -721.68% |
| 2008 Q1 | -1799.00 USD | 93.37% |
| 2007 FY | - USD | -156.28% |
| 2007 Q4 | -27.11 Thousand USD | -414.52% |
| 2007 Q2 | -1005.00 USD | 0.0% |
| 2007 Q3 | -5270.00 USD | -424.38% |
| 2006 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -3236.614% |
| IR-Med Inc. | -4.89 Million USD | -87.081% |
| Polarean Imaging plc | -11.19 Million USD | 18.249% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 2106.753% |
| Avitar, Inc. | -1.66 Million USD | -448.746% |
| AVITA Medical, Inc. | -39.56 Million USD | 76.87% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -686.254% |
| Össur hf. | 137.38 Million USD | 106.662% |
| Zecotek Photonics Inc. | -3.44 Million USD | -165.875% |
| QHSLab, Inc. | -91.29 Thousand USD | -9924.864% |
| Wellstar International, Inc. | -1.35 Million USD | -574.668% |
| Össur hf. | 137.38 Million USD | 106.662% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 193.635% |
| Escalon Medical Corp. | -58.46 Thousand USD | -15554.879% |
| Aurora Spine Corporation | -454.37 Thousand USD | -1914.182% |
| BrainsWay Ltd. | -2.31 Million USD | -296.019% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 2.424% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 265.748% |
| Vivos Inc. | -2.79 Million USD | -227.659% |
| MicroPort Scientific Corporation | -347.57 Million USD | 97.367% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -4529.446% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -448.499% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -2315.375% |
| Nanomix Corporation | -8.13 Million USD | -12.436% |
| Theraclion SA | -2.05 Million USD | -346.268% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -1194.429% |
| Positron Corporation | -1.45 Million USD | -530.237% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -431.51% |
| Lombard Medical, Inc. | -28.06 Million USD | 67.393% |
| ALR Technologies Inc. | -6.4 Million USD | -42.993% |
| Stratec SE | 39.91 Million USD | 122.929% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 9166.502% |
| Heart Tronics, Inc. | -14.85 Million USD | 38.399% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -7638.945% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 31.068% |
| VMS Rehab Systems, Inc. | -68.55 USD | -13350737.345% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -192.77% |
| Ingen Technologies, Inc. | -8639.00 USD | -105838.176% |
| Odyssey Group International, Inc. | -2.13 Million USD | -328.049% |
| United American Healthcare Corporation | -59 Thousand USD | -15411.863% |
| ECGI Holdings, Inc. | -2.99 Million USD | -206.043% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -1354.585% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -1680.458% |
| Urologix, Inc. | -6.34 Million USD | -44.262% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -638.445% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -1094.829% |
| SS Innovations International, Inc. | -20.37 Million USD | 55.084% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -4007.388% |
| Smith & Nephew plc | 1 Billion USD | 100.913% |
| NIOX Group Plc | 11.07 Million USD | 182.636% |
| Fuse Medical, Inc. | 1.83 Million USD | 598.661% |
| Broncus Holding Corporation | -25.19 Million USD | 63.681% |
| Brain Scientific Inc. | -7.93 Million USD | -15.356% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 2.544% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -49639.125% |